Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 1/2005

01-02-2005 | Case Report

Chyle and gout causing acute monoarthritis: some unusual findings

Authors: Venkata Ranga Rao Kodali, Nigel Andrew Dunn

Published in: Clinical Rheumatology | Issue 1/2005

Login to get access

Abstract

A 67-year-old man presented with acute monoarthritis of the right knee. Aspiration was carried out under aseptic precautions. This yielded a milky appearing fluid. Polarized microscopic examination confirmed uric acid crystals. The patient had a history of trauma to the joint. Acute monoarthritis of the knee can occur due to gout. Chylous effusions in the knee are rare. This combination of findings in the same joint has not been described in the literature. We emphasise the importance of history of trauma in acute monoarthritis. We discuss the unusual features of this case.
Literature
1.
Reiner DS (1993) Gouty arthritis following gunshot wound. New York State J Med 93:152–153
2.
Ruiz ME, Erickson SJ, Carrera GF, Hanel DP, Smith MD (1993) Monoarticular gout following trauma: MR appearance. J Comput Assist Tomogr 17:151–153PubMedCrossRef
3.
4.
Ifudu O, Tan CC, Dulin AL, Delano BG, Friedman EA (1994) Gouty arthritis in end-stage renal disease: clinical course and rarity of new cases. Am J Kidney Dis 23:347–351PubMed
5.
Lin HY, Rocher LL, McQuillan MA, Schmaltz S, Palella TD, Fox IH (1989) Cyclosporin-induced hyperuricemia and gout. N Engl J Med 321:287–292PubMedCrossRef
6.
White RE, Wise, Agedelo CA (1985) Post-traumatic chylous joint effusion. Arthritis Rheum 28:1303–1306PubMedCrossRef
7.
Metadata
Title
Chyle and gout causing acute monoarthritis: some unusual findings
Authors
Venkata Ranga Rao Kodali
Nigel Andrew Dunn
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-0962-z

Other articles of this Issue 1/2005

Clinical Rheumatology 1/2005 Go to the issue

Case Report

Relapsing arterial aneurysms in juvenile Behçet’s disease

Editorial

23 years editorship of Clinical Rheumatology: experiences and perspectives

Original Article

Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms

Original Article

Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases

Letter

Seronegative rheumatoid arthritis and gout

Case Report

p-ANCA-associated periaortitis with histological proof of Wegener’s granulomatosis: case report
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits